Mediastinal lymph node CD8alpha- DC initiate antigen presentation following intranasal coadministration of alpha-GalCer (Q80577046)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17615581%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

title

Mediastinal lymph node CD8alpha- DC initiate antigen presentation following intranasal coadministration of alpha-GalCer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17615581%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

Sung-Youl Ko

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17615581%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Kyoo-A Lee

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17615581%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Hyun-Jun Youn

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17615581%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Yeon-Jeong Kim

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17615581%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Hyun-Jeong Ko

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17615581%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Tae-Hwe Heo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17615581%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Mi-Na Kweon

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17615581%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Chang-Yuil Kang

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17615581%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

publication date

1 August 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17615581%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

1 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17615581%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17615581%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17615581%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

2127-2137

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17615581%20AND%20SRC:MED&resulttype=core&format=json

CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides

1 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636909

7 January 2021

alpha-Galactosylceramide therapy for autoimmune diseases: prospects and obstacles

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636909

7 January 2021

Natural killer T cell ligand alpha-galactosylceramide enhances protective immunity induced by malaria vaccines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636909

7 January 2021

The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636909

7 January 2021

Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636909

7 January 2021

New generation of mucosal adjuvants for the induction of protective immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636909

7 January 2021

Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636909

7 January 2021

Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell-mediated immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636909

7 January 2021

alpha-Galactosylceramide can act as a nasal vaccine adjuvant inducing protective immune responses against viral infection and tumor.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636909

7 January 2021

Tolerogenic dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636909

7 January 2021

Dendritic cells in immunity and tolerance-do they display opposite functions?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636909

7 January 2021

Dendritic cells in peripheral tolerance and immunity.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636909

7 January 2021

NKT cell ligand alpha-galactosylceramide blocks the induction of oral tolerance by triggering dendritic cell maturation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636909

7 January 2021

Mouse and human dendritic cell subtypes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636909

7 January 2021

Cutting Edge: Intravenous Soluble Antigen Is Presented to CD4 T Cells by CD8- Dendritic Cells, but Cross-Presented to CD8 T Cells by CD8+ Dendritic Cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636909

7 January 2021

The CD8alpha(+) dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636909

7 January 2021

Cutting Edge: Conventional CD8α+ Dendritic Cells Are Preferentially Involved in CTL Priming After Footpad Infection with Herpes Simplex Virus-1

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636909

7 January 2021

Cutting edge: conventional CD8 alpha+ dendritic cells are generally involved in priming CTL immunity to viruses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636909

7 January 2021

CD8alpha+ dendritic cells selectively present MHC class I-restricted noncytolytic viral and intracellular bacterial antigens in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636909

7 January 2021

CD8alpha-11b+ dendritic cells but not CD8alpha+ dendritic cells mediate cross-tolerance toward intestinal antigens

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636909

7 January 2021

IL-10-producing B220+CD11c- APC in mouse spleen

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636909

7 January 2021

A Clonogenic Bone Marrow Progenitor Specific for Macrophages and Dendritic Cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636909

7 January 2021

The regulatory role of Valpha14 NKT cells in innate and acquired immune response.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636909

7 January 2021

Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636909

7 January 2021

Bacillus anthracis edema toxin acts as an adjuvant for mucosal immune responses to nasally administered vaccine antigens

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636909

7 January 2021

A nontoxic chimeric enterotoxin adjuvant induces protective immunity in both mucosal and systemic compartments with reduced IgE antibodies.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636909

7 January 2021

Dynamics of Dendritic Cell Phenotype and Interactions with CD4+ T Cells in Airway Inflammation and Tolerance

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636909

7 January 2021

Influenza virus-induced dendritic cell maturation is associated with the induction of strong T cell immunity to a coadministered, normally nonimmunogenic protein

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636909

7 January 2021

Upper respiratory tract resistance to influenza infection is not prevented by the absence of either nasal-associated lymphoid tissue or cervical lymph nodes.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636909

7 January 2021

CD1d-restricted T cells license B cells to generate long-lasting cytotoxic antitumor immunity in vivo.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636909

7 January 2021

Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636909

7 January 2021

Dendritic cells: regulators of alloimmunity and opportunities for tolerance induction

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636909

7 January 2021

Interplay of cytokines and microbial signals in regulation of CD1d expression and NKT cell activation.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636909

7 January 2021

PPARgamma controls CD1d expression by turning on retinoic acid synthesis in developing human dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636909

7 January 2021

Engagement of glucocorticoid-induced TNF receptor costimulates NKT cell activation in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636909

7 January 2021

Identifiers

DOI

10.1002/EJI.200636909

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17615581%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference